Canada Life’s Esperion Therapeutics ESPR Stock Holding History

Canada Life’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-23,552	Closed	-$38K	–	2272
2023 Q1	$38K	Buy	23,552 +20,546	+683%	+$106K	﹤0.01%	2107
2022 Q4	$19K	Buy	+3,006	New	+$21.5K	﹤0.01%	2260
2021 Q4	–	Sell	-1,660	Closed	-$20K	–	2522
2021 Q3	$20K	Hold	1,660	–	–	﹤0.01%	2438
2021 Q2	$35K	Hold	1,660	–	–	﹤0.01%	2362
2021 Q1	$46K	Hold	1,660	–	–	﹤0.01%	2319
2020 Q4	$43K	Hold	1,660	–	–	﹤0.01%	2336
2020 Q3	$62K	Hold	1,660	–	–	﹤0.01%	2136
2020 Q2	$85K	Hold	1,660	–	–	﹤0.01%	2090
2020 Q1	$53K	Hold	1,660	–	–	﹤0.01%	2112
2019 Q4	$98K	Hold	1,660	–	–	﹤0.01%	2073
2019 Q3	$61K	Sell	1,660 -1,468	-47%	-$58.2K	﹤0.01%	1031
2019 Q2	$145K	Hold	3,128	–	–	﹤0.01%	2110
2019 Q1	$125K	Hold	3,128	–	–	﹤0.01%	1995
2018 Q4	$139K	Hold	3,128	–	–	﹤0.01%	2036
2018 Q3	$139K	Hold	3,128	–	–	﹤0.01%	2090
2018 Q2	$123K	Hold	3,128	–	–	﹤0.01%	2123
2018 Q1	$227K	Hold	3,128	–	–	﹤0.01%	1932
2017 Q4	$206K	Buy	3,128 +1,828	+141%	+$98.4K	﹤0.01%	1958
2017 Q3	$65K	Hold	1,300	–	–	﹤0.01%	2269
2017 Q2	$60K	Hold	1,300	–	–	﹤0.01%	2269
2017 Q1	$46K	Hold	1,300	–	–	﹤0.01%	2323
2016 Q4	$16K	Hold	1,300	–	–	﹤0.01%	2506
2016 Q3	$18K	Hold	1,300	–	–	﹤0.01%	2470
2016 Q2	$13K	Hold	1,300	–	–	﹤0.01%	2493
2016 Q1	$22K	Hold	1,300	–	–	﹤0.01%	2333
2015 Q4	$29K	Hold	1,300	–	–	﹤0.01%	2305
2015 Q3	$31K	Hold	1,300	–	–	﹤0.01%	2246
2015 Q2	$106K	Hold	1,300	–	–	﹤0.01%	1827
2015 Q1	$120K	Buy	+1,300	New	+$83.9K	﹤0.01%	1680

Other funds holding ESPR

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Canada Life's ESPR Position: Q2 2023 in Review

Canada Life sold out of Esperion Therapeutics (ESPR) in Q2 2023, closing a stake of 23,552 shares — an estimated $38K sold.

Canada Life first reported a position in ESPR in Q1 2015 and held it in 29 quarters. The position peaked at $227K in Q1 2018. 124 funds tracked by Wall St. Rank hold ESPR as of Q2 2023.

Canada Life reported no remaining Esperion Therapeutics position as of Q2 2023 after selling out during the quarter.
Canada Life sold 23,552 Esperion Therapeutics shares in Q2 2023, an estimated $38K.
Canada Life first reported a position in Esperion Therapeutics in Q1 2015 and held it in 29 quarters.
Canada Life's Esperion Therapeutics position peaked at $227K in Q1 2018.
124 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2023.

Based on Canada Life's 13F filing for Q2 2023, filed 10 Aug 2023.